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FLOW MANIPULATION IN BIOLOGICAL 
FLOWS USING VORTEX GENERATORS 
I. CROSS-REFERENCE TO RELATED 
APPLICATIONS 
2 
Flow stasis and recirculation regions have been shown to 
correlate to platelet deposition, particularly if these regions 
directly follow after a high shear stress region. The flow 
stagnation regions that occur at the blood-material interface 
on cardiovascular devices immediately adjacent to these high 
shear stress flow environments can promote damaged blood 
elements deposition, leading to thrombus formation on the 
cardiovascular devices. 
Another important factor affecting the degree of blood 
The present application is related to U.S. provisional patent 
application having Ser. No. 60/865,919 titled "Flow Manipu-
lation Devices for Prosthetic Heart Valves" filed Nov. 15, 
2006 which is hereby incorporated by reference in its entirety 
and with priority of the present application being claimed to 
Nov. 15, 2006. 
II. FIELD OF INVENTION 
10 damage is the amount of time the blood element spends in the 
high shear stress region. Shear-induced platelet activation and 
hemolysis are known to be a result of extended exposure of 
blood cells to high levels of shear stress. Previous studies have 
emphasized the importance of both stress magnitude and 
The present invention relates to systems and methods for 
manipulating biological flows. More particularly, the present 
invention relates to managing flow through medical devices 
to reduce risk of adverse events attributable to shear stress. 
15 exposure time as important parameters in assessing shear 
related blood cell damage. The closing flow transients that 
occur during the leaflet closure phase are associated with the 
formation of a strong leakage jet in the B-datum region pre-
ceded by strong counter rotating starting vortices of high 
20 shear rates. 
III. BACKGROUND OF THE INVENTION There exists a need for systems and methods for flow 
control devices that can minimize the magnitude of shear 
stresses experienced by blood elements. The flow control 
devices should counteract the formation of strong vortices 
It is well established that adverse events (such as blood 
element or cell damage, thrombus formation, and platelet 
activation) can be caused by flow-induced shear stresses. 
These factors may seriously limit the performance of a broad 
range of devices used to transport biological fluids. By way of 
non-limiting example, such devices include cardiovascular 
hardware, prosthetic valves, stents, bypass pumps, and flow-
assist devices as well as conduits for transporting such fluids. 
25 thereby reducing the overall platelet activation potential of 
cardiovascular devices. In addition, the flow control devices 
should mitigate the adverse effects of high shear stress in 
blood-contacting devices and manipulate secondary vorticity 
concentrations within the blood flow. Furthermore, the flow 
30 control devices should enhance cross stream mixing and 
momentum transfer to diminish local velocity gradients and 
corresponding shear stress distributions. 
In particular, there exists a large body of scientific literature 
that has emphasized the significant risk associated when 
blood elements are subjected to non-physiological hemody-
namic shear stresses in in-vivo devices (heart valves, flow 
assist devices etc.), and the severe limitations of non in-vivo 35 
devices (bypass pumps, dialysis machines, heart-lung instru-
ments, or syringe needles, etc.). 
Implanted ventricular assist devices (V ADs) have also been 
implicated in thromboembolic events. Other known 
examples of blood damage in cardiovascular systems include 40 
centrifugal blood pumps that are used during bypass surgery 
and have been shown to cause hemolysis and platelet activa-
tion, which can lead to thromboembolism. Also, blood flow 
over surfaces of vascular stents (coronary or peripheral 
stents) can induce shear stress resulting in thrombus forma- 45 
ti on. 
Shear stress can lead to coagulation and thromboemboli 
formation by either damaging the red blood cell (RBC) or by 
mechanically activating the platelet. High levels of shear 
stress can tear the RBC membrane, thus exposing tissue fac- 50 
tor to the plasma and initiating the tissue factor pathway of the 
coagulation cascade. Shear stress can also trigger the coagu-
lation cascade by activating platelets directly. Platelets are 
activated by shear stress that results in mechanotransduction 
IV. SUMMARY OF THE INVENTION 
The present application discloses various devices for use in 
combination with a fluid flow having a biologic component 
and subject to an adverse response to shear stress. The device 
includes a surface in contact with the flow of the fluid. The 
surface has a longitudinal direction extending from a leading 
end toward a trailing end and aligned with a direction of the 
flow. The device is susceptible to fluid flow phenomena 
including boundary layer formation within the flow sufficient 
for a resulting shear stress to induce the thrombogenic 
response, or free shear flow formation such as jet, separation 
zones of sufficient characteristic to induce the thrombogenic 
response. The surface includes a surface feature sufficient to 
alter the fluid flow such as to reduce the overall shear stress 
that the biologic components may encounter while transiting 
through the device. 
In addition, aspects of the present invention include an 
implant for chronic placement in a patient's body. The 
implant has a lumen defining a blood flow path for a blood 
flow having flow characteristics including a flow rate. The 
of the force to a GP! b receptor. 55 implant has a surface at least partially defining the lumen and 
in contact with the blood flow. The surface has a longitudinal 
direction extending from a leading end toward a trailing end. 
In addition, the device is susceptible to fluid flow phenomena 
This mechanotransduction enables binding of the GP! b 
receptor to Von Willebrand Factor (vWF) and a subsequent 
influx of calcium ions, resulting in platelet activation. Upon 
activations the GpIIb/IIIa receptor is activated and can then 
bind to other ligands such as fibrinogen, vWF, fibronectin, 60 
and vitronectin. The coagulation cascade is propagated and 
can lead to the formation of thrombin-anti-thrombin III 
(TAT), which is a relative measure of thrombin formation. 
RBCs are vulnerable to sub-lethal damage at shear stresses of 
500 dynes/cm2 and by as little as 10-100 dynes/cm2 in the 65 
presence of foreign surfaces. In addition, platelet activation 
can occur at shear stresses as low as 60-80 dynes/cm2 . 
including boundary layer formation within the flow sufficient 
for a resulting shear stress to induce the response, or free shear 
flow formation such as jet, separation zones of sufficient 
characteristic to induce the thrombogenic response. The sur-
face includes a surface feature sufficient to alter the fluid flow 
such as to reduce the overall shear stress that the blood may 
encounter while transiting through the device. 
Furthermore, the present invention includes examples of a 
device for receiving blood from a patient, treating the blood 
US 8,834,911 B2 
3 
and returning the treated blood to the patient. The device 
comprises a plurality of blood flow pathways for containing 
and directing a blood flow. The blood flow has flow charac-
teristics including a flow rate. At least one of said pathways 
has a surface at least partially defining the pathway and in 
contact with the blood flow. The surface has a longitudinal 
direction extending from a leading end toward a trailing end 
and the surface is susceptible to inducing boundary layer 
formation, jet formation, or flow separation within the blood 
flow. The surface has characteristics sufficient to induce a 
thrombogenic response. Furthermore, the surface includes a 
surface feature sufficient to alter the blood flow such as to 
reduce the overall shear stress that the blood may encounter 
while transiting through the device. 
V. BRIEF DESCRIPTION OF THE DRAWINGS 
Non-limiting and non-exhaustive embodiments are 
described with reference to the following figures, wherein 
like reference numerals refer to like parts throughout the 
various views unless otherwise specified. 
FIG. 1 is a schematic representation of a prior art device 
having surfaces in chronic contact with a patient's blood flow 
and having no passive means for reducing shear stress in the 
flow; 
FIG. 2 is a schematic representation of the device of FIG. 1 
modified according to the present invention; 
FIG. 3 is the view of FIG. 2 illustrating flow response to the 
modification of the present invention; 
FIGS. 4 and 4A depict planer protuberances consistent 
with embodiments of the invention; 
4 
throughout this specification, protrusion, protuberance, sur-
face irregularity, surface indentation, and vortex generator 
may be used interchangeably. 
The present invention will be described in a preferred 
embodiment of passive surface modifications to avoid exces-
sive shear stress in devices in contact with blood flow. Such 
devices may be chronically implanted devices (e.g., LVAD' s, 
stents, valves, etc.) or may be external devices (e.g., blood 
pumps, blood oxygenators, etc.) or may be blood conduits 
10 (e.g., catheters). Further, while use in blood flow is a currently 
most preferred embodiment, the present invention is appli-
cable to biological fluids in general (including therapeutic 
fluids such as therapeutic agents such as cell components, 
15 
drugs or the like administered in an aqueous medium). 
FIG. 1 illustrates a prior art device 100 with a surface in 
contact with a patient's blood flow. The device 100 includes 
walls 102and104. As blood flows through the device 100, a 
bulk flow 126 contacts the device 100 at the leading edges 
102a, 104a of walls 102and104. As the bulk flow 126 flows 
20 through the device 100, boundary layers 122 and 124 may 
form in the entrance region of the device 100. Depending 
upon the length ("L") and diameter ("D") of the device 100, 
fully developed flow may or may not develop. Boundary 
layers 122and124 cause shear stresses to develop along walls 
25 102 and 104. 
Referring now to FI GS. 2 and 3, a schematic representation 
of a device 300 according to various aspects of the present 
invention is shown. Device 300 includes surfaces 302 and 304 
having various vortex generators 206, 208, and 110 spaced 
30 from leading edges 302a and 304a along a flow direction 
(indicated by the arrows in FIG. 3). Note that while FIGS. 2 
and 3 show three different types of vortex generators depicted 
on surfaces 302 and 304 it is contemplated that a single type FIG. 5 depicts hemispherical protuberances consistent 
with embodiments of the invention; 
35 FIG. 6 depicts maps of instantaneous vorticity fields at the 
of vortex generator or two or more vortex generators may be 
implemented on device 300. 
Vortex generators 306, 308, and 310 may be characterized 
by characteristics including but not limited to angle of attack, 
height, depth, flexibility, and spacing sufficient to create a 
region of vortex formation proximate vortex generators 306, 
308, and 310. It will be appreciated that selection of such 
characteristics for a given flow characteristic (such as flow 
moment of valve closure; 
FIG. 7 depict contour plots of mean velocity for the steady 
b-datum jet from the valve without and with rectangular vor-
tex generators and Reynolds shear stress for the steady b-da- 40 
tum jet from the valve without and with rectangular vortex 
generators; 
FIG. 8 depicts comparison of TAT concentration with and 
without vortex generators; 
FIG. 9 depicts shows a situation where embodiments of the 
present invention may be employed on a device external to a 
patient; 
FIG. 10 depicts a situation where embodiments of the 
present invention may be deployed on a device internal to the 
patient; 
FIG. 11 depicts a bileaflet heart valve experiencing leak-
age; and 
FIG. 12 depicts a bileaflet heart valve having flexible tips. 
VI. DETAILED DESCRIPTION OF A 
PREFERRED EMBODIMENT 
Various embodiments are described more fully below with 
reference to the accompanying drawings, which form a part 
hereof, and which show specific embodiments of the inven-
tion. However, embodiments may be implemented in many 
different forms and should not be construed as limited to the 
embodiments set forth herein; rather, these embodiments are 
provided so that this disclosure will be thorough and com-
plete, and will fully convey the scope of the invention to those 
skilled in the art. Accordingly, the following detailed descrip-
tion is, therefore, not to be taken in a limiting sense. Note that 
rate) is well within the skill level of one of ordinary skill in the 
art having the benefit of the present disclosure. 
Vortex generators 306, 308, and 310 may induce the for-
45 mation of secondary counter-rotating streamwise vortex pairs 
314 which interact with the shear layer and induce cross 
stream mixing. This cross-stream mixing leads to broadening 
of the jet stream and to dissipation of small-scale motions. 
In various aspects of the invention, vortex generators such 
50 as vortex generators 310 may be conformable. The interest in 
conformable flow control elements stems from the fact that 
they may be designed to adapt their functionality to the cycli-
cal state of the embedding flow during a cardiac cycle. For 
example, vortex generators that are highly effective for reduc-
55 ing blood damage during valve closure may be pushed out of 
the way (e.g., bend towards the surface) when the embedding 
flow reverses its direction to minimize losses. Alternatively, 
the flexible flow control devices may be reconfigured and 
have different functionality to beneficially affect the reverse. 
60 In addition, the functionality of the passive devices can be 
potentially enhanced by allowing them to interactively oscil-
late as they shed streamwise vorticity. 
FIG. 12 shows an implementation of flexible tip passive 
flow control on the contemporary rigid bileaflet heart valve 
65 1200 comprising flexible tips 1202 and leaflets 1204 and 
1206. Flexible tips 1202 help ensure smooth closing of heart 
valve 1200 thus eliminating the typical colliding, nature of 
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leaflets 1204 and 1206 closure. The closure has been attrib-
uted to formation of extreme pressure gradients that lead to 
cavitation and hemolysis. Flexible tips 1202 help ensure that 
the added compliance at the contact points provide a smooth 
contact as well as a damping effect to eliminate the water 
hammer effect. Additionally, it is anticipated that flexible lips 
1202 may greatly reduce leakage through a b-datum and 
peripheral gaps during a cardiac cycle's leakage phase. 
6 
shear flows. Passive flow control devices may have morphol-
ogy and structural features to alter the flow over the device's 
surface and active flow control (e.g., movable fins or other 
movable protuberances) to achieve drag reduction, thrust pro-
duction, and propulsive efficiency. These devices generally 
use distributed element arrays (e.g. surface irregularities) that 
may protrude above the surface or indentations or grooves 
that penetrate into the device's surface. 
Vortex generators that protrude from the surface may Protuberance or other surface irregularities may be rigid 
flow control elements. In addition to being rigid, protuber-
ance or other surface irregularities may be flexible passive 
flow control elements. The use of flexible elements for flow 
control is attractive because it offers expanded control author-
ity. The interest in conformable flow control elements stems 
from the fact that they can be designed to adapt their func-
tionality to the cyclical state of the embedding flow during a 
flow cycle. For example, vortex generators that are highly 
effective for reducing blood damage during valve closure can 
10 include transverse cylinders, plates, and airfoils that may be 
oriented parallel or normal to the flow and within the bound-
ary layer or shear layer or any other location where there is 
fairly strong shear within the flow. In the parallel configura-
tion these plates or airfoils may shed transverse (i.e. span-
be pushed out of the way (e.g., bend towards the surface) 
when the embedding flow reverses its direction to minimize 
losses. In addition, the flexible flow control devices can be 
reconfigured and have different functionality to beneficially 
affect the reverse. In addition, the functionality of the passive 
devices can be potentially enhanced by allowing them to 
interactively oscillate as they shed streamwise vorticity. 
15 wise) vortices along the device and may lead to the wall 
boundary layer prematurely transitioning to turbulent flow 
(i.e. boundary layer "tripping"), turbulent flow structure 
modification, or may break up larger vortical eddies that are 
present in the flow. The plates or airfoils (i.e. surface irregu-
20 larity) may act as mixers to facilitate avoidance of regions 
where the shear may be strong. This may be done by forcing 
flow from either slow moving fluid to rapid, fast moving fluid 
or forcing flow from fast moving fluid into slow moving fluid. 
By forcing flow from slow moving fluid to fast moving fluid 
25 the velocity may equalize, (i.e. the overall velocity gradient 
may become smaller). In addition to altering boundary layer 
formation, the vortex generators may also alter free shear 
flows that are generated by the device (e.g. leakage jets, shear 
layers etc.). For instance, a heart valve 1100 may comprises 
The angle of attack, height, depth, and spacing of vortex 
generators 306, 308, and 310 are great enough to retard 
boundary layer formation thereby reducing shear stress at 
surfaces 302 and 304. The internal blood flow within device 
300 is shown at 326' and the approaching flow is shown at 
326. In addition, the height and spacing of vortex generators 
306, 308, and 310 are small enough to discourage flow stag-
nation (e.g. pooling, clotting, and clumping of the flow) 
proximate vortex generators 306, 308, and 310. Again, deter-
mination of specifics of such features for a given flow is 35 
within the skill level of one of ordinary skill in the art having 
the benefit of the teachings of the present invention. Also, note 
that vortex generators 306, 308, and 310 can be at arbitrary 
angles to surfaces 302 and 304 and the flow. In addition, the 
angle relative to surfaces 302 and 304 may be device specific. 40 
30 leaflets 1102 and 1104. As a flow 1106 flows through heart 
valve 1100, the can be hinge leakage 1108 and leakage jet 
1110 formation. 
The height and spacing of vortex generators 306 and 310 
are such that vortex generators 306 and 310 do not substan-
tially reduce a cross-sectional area in the flow direction or 
volumetric flow rate through device 300. Characterization of 
a substantial reduction in the cross-sectional area orvolumet- 45 
ric flow rate may be a noticeable reduction in blood flow to the 
point that the effective diameter or other characteristic length 
associated with measuring the cross-sectional area or volu-
metric flow rate is reduced. For example, if vortex generators 
306 and 310 reduce the cross-sectional area by 10-15%, this 50 
may constitute a substantial reduction in the cross-sectional 
area. Another example may be that if vortex generators 306 
and 310 reduce the volumetric flow rate to the point vortex 
generators 306 and 310 simulate coronary artery plaque or 
other artery blockage, this may constitute a substantial reduc- 55 
tion in the volumetric flow rate. 
Note that depending on the flow (i.e. the material flow, flow 
speed, overall cross-sectional area, hydraulic diameter. Rey-
nolds Number (Re), Euler Number (Eu), etc.) a reduction in 
the cross-sectional area by 10-15% does not necessarily 60 
translate to increased energy losses (i.e. a substantial reduc-
tion in the cross-section area). A decrease in overall shear 
stress experienced by the fluid translates to lower drag and 
lesser energy losses. 
As described above, embodiments of the present invention 65 
utilize passive flow control devices for manipulating and con-
trolling the evolution of both free and wall-bounded turbulent 
Low-aspect ratio (i.e., short span) plates and airfoils that 
are mounted normal to the surface along their (long) chords 
are called vortex generators. Because the vortex generators 
are mounted at an angle of attack relative to the oncoming 
flow, they form either clockwise or counterclockwise (de-
pending on their orientation) "wing tip" streamwise vortices. 
The vortex generators are typically arranged in spanwise 
arrays that can be formed with single (same orientation) or 
symmetric pairs to produce either single-sign or counter 
rotating streamwise vortex pairs. 
Vortices scale with the characteristic dimensions of the 
generating elements and lead to enhancement of entrainment 
(e.g., transfer of high-momentum fluid towards the surface) 
and small-scale fluid mixing within the embedding flow field. 
In external and internal flows, flow separation suppression or 
mitigation and mixing enhancement within free shear flows 
are typically dominated by large coherent vortical structures. 
Flow control devices that are embedded in the flow surface 
include dimples, riblets, and small-scale streamwise grooves 
that can reduce turbulent skin friction. These rib lets break up 
spanwise vortices and reduce the surface shear stress and 
momentum loss by preventing eddies from transporting high 
speed fluid close to the surface. 
Free turbulent jets demonstrate that the interaction 
between the jet's predominantly azimuthal vorticity and the 
streamwise vortices induced by passive vortex generators can 
lead to mixing enhancement and therefore to reduction in 
shear. Moreover, the increase in small-scale motion within 
the flow leads to enhancement and consequently to dissipa-
tion of turbulent fluctuations. 
Axial vorticity may be introduced by placing tabs at the jet 
exit such that they protruded into the flow with an area block-
age of approximately 1-2% per tab. As little as two tabs may 
significantly increase mixing sufficiently to reduce the poten-
tial core length and increase the decay of the centerline veloc-
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ity. This increased mixing and decay may increase jet spread-
ing and reduce the flow shear. Streamwise vorticity 
generation at the jet exit may be promoted by enforcing 
azimuthal excitation through vortex generators or tabs at the 
edge of the nozzle or by using corrugated, lobed, or indented 
nozzle edges. 
As described above, surface irregularities or vortex gen-
erators may be placed in any type of device used to transport 
biological materials or materials susceptible to damage where 
there may be increased shear levels that may lead to damage 10 
due to flow separation internally or bifurcation within the 
device. For example, vortex generators may be used in car-
diovascular device to reduce shear levels that may lead to 
blood damaged due to flow separation or bifurcation within 
blood vessels. The flow separation and bifurcation may cause 15 
separation and recirculation that may also lead to damage of 
the flow material. 
The passive vortex generators may be fabricated using 
molding technologies and bio-compatible polymeric materi-
als (e.g., PDMS). As noted above, the elasticity and other 20 
mechanical properties of the molding material may be 
selected so that the fins can bend appreciably (and therefore 
minimize their cross stream protrusion) when the flow over 
the leaflets reversed direction. 
8 
such that the velocity field was captured throughout the car-
diac cycle of 860 ms with 20 ms increments. The vorticity 
fields capture regurgitant jets for a heart valve having no 
vortex generators, rectangular or planer vortex generators, 
and hemispherical vortex generator. 
The small-scale vorticity concentrations associated with 
the strong momentary jet are clearly visible in the three PIV 
"snapshots". These vorticity distributions indicate the pres-
ence of high-shear flow domains that are advected with the jet 
flow. 
The sample PIV snapshots in FIG. 6 show the remarkable 
impact of the vortex generators on the momentary jet flow. 
For both planer and hemispherical vortex generator arrays, 
the jet becomes highly diffused and well mixed as may be 
concluded from the structure of the voracity concentrations 
which are very weak. It is also interesting to note that at least 
by the measure of the vorticity concentrations, the rectangular 
vortex generators appear to be more effective than the hemi-
spherical generators. 
Ensemble-averaged distributions of the Reynolds stresses 
for the three configurations of FIG. 6 (shown in FIG. 7) 
confirms that the passive vortex generators strongly reduce 
the magnitude of the turbulent fluctuations within the flow 
owing to increased dissipation. The PIV measurements indi-
Passive flow control devices can be effectively realized 
using advanced fabrication technologies. In particular, soft 
polymers (e.g., PDMS) that are biocompatible can be adapted 
for the fabrication of intricate surface devices using a combi-
nation of rapid prototyping (e.g. solid object printing) and 
soft lithography. Moreover, these elastomers can be fabri-
cated in submicron features with no discernible pattern deg-
radation or surface distortion. Submicron resolution molds 
can be generated by electron beam lithography, for example, 
25 cate that the vortex generators have a strong effect on the jet 
flow field. The mean velocity distributions (FIG. 7) indicate 
that in the presence of the vortex generators the shear layers of 
the jet are significantly narrower owing to increased mixing 
along the jet's edges and that the core of the jet is moving a 
30 faster. 
to yieldnano-scalepatterns in replica molded elastomers. The 
effectiveness of surface integrable flow control devices may 35 
facilitate their implementation using new, nano-and micro-
fabrication technologies may allow custom-fitting these 
devices to specific patients. 
Referring now to FIGS. 4 and 5, vortex generators 206 and 
210 may be substantially planer (FIG. 4), substantially hemi- 40 
spherical (FIG. 5), a combination of substantially planer and 
substantially hemispherical shapes, serrated edges either in or 
normal to the plane of the leaflet, etc. Planar protuberances 
(e.g. rectangular vortex generators) consisted of rectangular 
fins 402. Each fin may produce a streamwise (wingtip) vortex 45 
where the sense of the vorticity (i.e., clockwise or counter 
clockwise) may depend on the angle of the fins 402 relative to 
a free stream. For example, consistent with embodiments of 
the present invention, each fin 402 may be 1 mm high (a base 
0.5 mm thick) and may have an angle of attack of ±15° 50 
degrees relative to an oncoming flow. In other aspects of the 
invention, protuberance may be based on an array of stag-
gered hemispherical protuberances 502. For example, hemi-
spherical protuberances 502 may have a diameter of 1 mm 
with an edge to edge spacing of 0.5 mm. In addition, while 55 
FIGS. 4 and 5 show the protuberances substantially parallel 
(FIG. 4) and substantially perpendicular (FIG. 5) to the blood 
flow direction, it is contemplated that the protuberances may 
The strong impact of the passive vortex generators on the 
evolution of the jet flow may be discerned from distributions 
of the Reynolds stresses (FIG. 7). This data shows a strong 
reduction in the magnitude of the velocity fluctuations within 
the jet and therefore in the instantaneous mechanical shear to 
which the blood cells are subjected. The data show that the 
Reynolds stresses decrease by (nominally) 50%. 
As discussed above, TAT is an established measure to 
access the pro-coagulant potential of various valves. In order 
to confirm that the changes in the flow induced by the vortex 
generators also alter the pro-coagulant nature of the valve, a 
series of measurements were conducted in vitro. Heart valves 
with and without vortex generators were tested in a flow loop 
to measure the TAT concentration in blood over a period of 
one hour at 15 min intervals. 
FIG. 8 depicts a comparison of TAT measurements (taken 
at 15 min intervals) in the three configurations considered 
here (i.e. the baseline valve, and in the presence of rectangular 
and hemispherical vortex generators). This data clearly show 
that TAT concentration increases steadily with time for all 
three cases indicating a gradual progress in overall blood 
coagulation levels in the system. However, the total TAT 
concentration in the presence of the vortex generators is sub-
stantially lower than in the baseline valve. In particular, the 
presence of the rectangular vortex generators leads to a 42% 
decrease in TAT concentration compared to the baseline. The 
production rate with the hemispherical vortex generators is 
higher than with the rectangular generators, but still signifi-
cantly lower than in the absence of passive flow control (base-be parallel, perpendicular, or a combination of both to blood 
flow direction. 60 line). The significance of these results is underscored by the 
fact that they actually provide conservative estimates of the 
reduction in blood damage and that in reality these effects 
may be considerably higher. This is due to background blood 
Referring now to FIG. 6, FIG. 6 depicts maps of instanta-
neous vorticity fields at the moment of valve closure. The flow 
characteristics of the transitory jet and the influence of vortex 
generators were investigated using high resolution particle 
image velocimetry (PIV). The plane of measurement was 65 
aligned along the centerplane of the chamber and perpendicu-
lar to the leaflet axis. The measurements were phase locked 
damage and activation that are caused by other components in 
the loop such as the pump, loop fittings etc. 
Embodiments of the present invention may be utilized on 
mechanical heart valves and other replacement cardiovascu-
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lar devices that are rigid. In addition, embodiments of the 
present invention may be utilized on replacement cardiovas-
cular devices and other devices in chronic contact with blood 
flow that are flexible and mimic real physiological heart 
valves, arteries and physiological structures. The use of flex-
ible elements (e.g. surface edges and vortex generators) for 
cardiovascular flow control offers expanded control authority 
coupled with advanced, batch fabrication technologies. 
10 
The integration of vortex generators on material used to 
manufacture cardiovascular or other devices may be accom-
plished while still using bio-compatible materials such as 
PDMS that can be molded easily and quickly. Even when 
rigid cardiovascular devices are used, flexible materials may 
be integrated to form vortex generators. For example, one 
complaint of current heart valves does not have anything to do 
with the physiological applications but with "clicking". Dur-
ing opening and closing of the heart valve the metallic edges 
FIG. 9 schematically illustrates the present invention 
employed on a device 902 external to a patient 904. For 
example, FIG. 9 shows device 902 connected to patient 904 
via conduits 906 and 908. Any number of components within 
device 902 (or conduits 906, 908) may be fitted with vortex 
generators in efforts to minimize damage to biological fluids. 
For instance, device 902 may be a blood pump used during 
heart surgery. Piping within device 902 may be fitted with 
vortex generators as well as facets of other internal compo-
lO nents. In addition, conduits 906 and 908 may also be fitted 
will vortex generators to minimize damage to biological flu-
ids. By way of non-limiting example, device 902 may 
include: blood pumps, blood oxygenators, dialysis machines, 
15 drug delivery machines, syringes, etc. 
While FIG. 9 has been described where device 902 receives 
biological fluids from patient 904 and then returns biological 
fluids to patient 902, it is contemplated that device 902 may 
only receive biological fluids from patient 904. For instance, 
device 902 may be any device used by agencies such as the 
RED CROSS during blood drives, or devices used by physi-
cians do collect biological samples such as tissue and urine 
from patients. In addition, it is further contemplated that 
device 902 may only supply biological fluids to patient 904. 
of the leaflets strike one another producing a clicking noise. In 
various aspects of the invention, a device may integrate a 
flexible material with hard/rigid materials during manufac- 20 
turing to create soft tips at the edges to eliminate the clicking 
noise commonly associated with purely metallic heart valves. 
For instance, the edges of hear valve leaflets may be a flexible 
material, (i.e. a quiet material) and a majority of the leaflet 
surface could be rigid (See FIG. 12). 
During manufacturing vortex generators may be molded 
into soft and rigid materials. Molding the vortex generators 
into the materials may eliminate the need to separately glue 
them onto the surface. For example, an implantable medical 
device could be molded out of flexible materials like PDMS. 30 
25 For example, device 902 may be a device used during che-
motherapy to deliver cells, drugs, blood, or other medical and 
biological elements to patient 904. 
FIG. 10 shows the present invention employed on a device 
1002 internal to a patient 1004. For example, FIG. 10 shows 
device 1002 implanted into patient 1004. If device 1002 con-
tains multiple components or facets, any number of device 
1002's components or facets may be fitted with vortex gen-
erators in efforts to minimize damage to biological fluids. For 
instance, device 1002 may be a stent used to prop open an 
PDMS elastomer can conform to extremely small (submi-
cron) features with no discernible pattern degradation or sur-
face distortion. Moreover, these fabrication technologies sug-
gest themselves as viable vehicles for realizing passive flow 
control devices in cardiovascular systems because soft poly-
mers such as PDMS are stable, non-toxic, low-cost, with 
appealing physical and chemical properties that are also bio-
and micro-fabrication compatible. Furthermore, some of 
these materials can be selected to have desirable properties 
such as optical transparency, tunable surface chemistry, ther- 40 
ma! stability, good bonding characteristics, elasticity, high-
gas, and low-water permeability. 
35 artery and the stent's facets may be fitted with surface pro-
trusions and surface indentations to minimize damage to 
blood flowing though the stent. By way of example and not 
limitation, device 1002 may include heart valves, stents, 
LVAD's, etc. 
In other instances, vortex generators may be utilized in 
systems where flow through the system may experience a 
discontinuity (e.g. between two different size pipes or tubes) 
giving rise to a velocity jump as the flow goes from the large 
diameter tube to a small diameter tube or vice versa. Surface 
45 irregularities may be used to help mitigate the effects of any 
sudden changes in velocity. 
Currently, a patient is measured for a prosthetic device and 
after manufacturing, the device is implanted. This can lead to 
problems in that the measurements may be taken via ultra-
sound technology and at best are estimates of the size needs. 
Many biocompatible materials can be molded quickly allow-
ing for cardiovascular devices to be manufactured using, 
rapid prototyping technologies. Using rapid prototyping 
technologies and a surgeon may, in real time, manufacture a 50 
replacement cardiovascular device while the patient is on the 
operating table. For instance, after opening the patient's chest 
cavity the surgeon may measure the patient's heart directly. 
Once the direct measurements are taken, the actual machines 
necessary to manufacture a device (e.g. heart valve, replace- 55 
ment artery, stent) may be in the operating room and the 
replacement device fabricated in real time using direct mea-
surements, not ultra sound measurements. 
The passive vortex generators may be fabricated using 
molding technologies and biocompatible polymeric materi- 60 
als (e.g., PDMS). An aspect of the flexible vortex generators 
is the ability to prescribe the mechanical properties of the 
material and therefore the relaxation time following the 
change in flow direction. For example, the relaxation time can 
be scaled to optimize performance such that the vortex gen- 65 
erators are fully extended only when the transitory jet reaches 
its full speed (i.e., before the valve closes completely). 
Reference may be made throughout this specification to 
"one embodiment," "an embodiment," "embodiments," "an 
aspect," or "aspects" meaning that a particular described fea-
ture, structure, or characteristic may be included in at least 
one embodiment of the present invention. Thus, usage of such 
phrases may refer to more than just one embodiment or 
aspect. In addition, the described features, structures, or char-
acteristics may be combined in any suitable manner in one or 
more embodiments or aspects. Furthermore, reference to a 
single item may mean a single item or a plurality ofitems,just 
as reference to a plurality of items may mean a single item. 
Moreover, use of the term "and" when incorporated into a list 
is intended to imply that all the elements of the list, a single 
item of the list, or any combination ofitems in the list has been 
contemplated. 
One skilled in the relevant art may recognize, however, that 
the invention may be practiced without one or more of the 
specific details, or with other methods, resources, materials, 
etc. In other instances, well known structures, resources, or 
operations have not been shown or described in detail merely 
to avoid obscuring aspects of the invention. 
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While example embodiments and applications of the 
present invention have been illustrated and described, it is to 
be understood that the invention is not limited to the precise 
configuration and resources described above. Various modi-
fications, changes, and variations apparent to those skilled in 
the art may be made in the arrangement, operation, and details 
of the methods and systems of the present invention disclosed 
herein without departing from the scope of the claimed inven-
tion. 
12 
6. A device according to claim 1 wherein the surface further 
includes a plurality of indentations along the length of the 
surface with the indentations dimensioned and positioned to 
induce the advected vortices in the flow on a trailing side of 
the plurality of indentations. 
7. A device according to claim 5 wherein the surface sur-
rounds the flow of fluid and defines a cross-sectional area 
transverse to the direction of flow and a first reduction in the 
area attributable to the projections does not adversely affect 
The above specification, examples and data provide a 
description of the manufacture and use of the invention. Since 
many embodiments of the invention can be made without 
departing from the spirit and scope of the invention, the 
invention resides in the claims hereinafter appended. 
10 flow rate through the device. 
8. A device according to claim 1 wherein a spacing between 
the projections is sized to avoid stagnant flow formation in the 
spacing. 
We claim: 15 9. A device according to claim 1 wherein the surface fea-
ture is adapted to induce boundary layer tripping in a first flow 
direction and not in a second flow direction. 
1. An implantable device for chronic placement in a 
patient's body, the device for use in combination with a flow 
of a fluid having a biologic component and subject to an 
adverse response to shear stress, the device including a sur-
face in contact with the flow of the fluid, the surface compris-
ing: 
10. A device according to claim 1, wherein the surface 
feature projecting into the flow are sufficient to induce for-
20 mation of secondary counter-rotating streamwise vortex 
pairs. 
11. A device according to claim 1, wherein the surface 
feature is flexible. 
a longitudinal direction extending from a leading end 
toward a trailing end and aligned with a direction of the 
flow, the surface susceptible to inducing boundary layer 
formation within the flow sufficient for a resulting shear 
stress to induce the adverse response, and 
12. A device according to claim 1, wherein the surface 
25 feature is located at the trailing end of the surface. 
a surface feature projecting into the flow sufficient to 
induce boundary layer tripping in the flow to retard 
growth ofboundary layer formation along the length and 
create advected vortices, wherein the surface feature is a 30 
movable protuberance. 
2. A device according to claim 1 wherein the fluid is blood 
and the adverse response is a thrombosis formation response. 
3. A device according to claim 1 wherein the biological 
component is a cell or cell component and said adverse 35 
response is cell injury from the resulting shear stress. 
4. A device according to claim 1 wherein the surface is in 
contact with blood flow. 
5. A device according to claim 1 wherein the plurality of 
projections are located along the length of the surface with the 40 
projections dimensioned and positioned to induce the 
advected vortices in the flow on a trailing side of the projec-
tions. 
13. A device according to claim 1, wherein, the surface 
feature is arranged to break up spanwise vortices and reduce 
surface shear stress and momentum loss. 
14. A device according to claim 1, wherein the surface 
feature is arranged to prevent eddies from transporting high 
speed fluid close to the flat surface. 
15. A device according to claim 1, wherein the surface 
feature is configured to oscillate. 
16. A device according to claim 1, wherein the surface 
feature is non-continuous. 
17. A device according to claim 1, wherein the surface is 
otherwise smooth except for the surface feature protruding 
from the surface. 
18. A device according to claim 1, wherein the surface 
feature inhibits flow stagnation. 
* * * * * 
